Thromboembolic Complications in Mild Covid-19 Cases

NCT06695377 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 961

Last updated 2024-11-19

No results posted yet for this study

Summary

The aim of the study is to investigate the frequency of thromboembolic complications and the factors influencing them in COVID-19 cases that did not require hospitalization. For this purpose, patients registered at two different family health centers in Istanbul were retrospectively screened, and their status regarding post-COVID-19 thromboembolic events was recorded. The sociodemographic characteristics, medical history, COVID-19 treatments received, comorbidities, and current medications of all patients were examined and compared with the occurrence of complications.

Conditions

  • COVID 19
  • Thromboembolic and Bleeding Complications
  • Thromboembolism, Venous
  • Post COVID-19

Sponsors & Collaborators

  • Marmara University Pendik Training and Research Hospital

    lead OTHER

Principal Investigators

  • Buğu Usanma Koban · Marmara University Medical Faculty

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-06-30
Completion
2022-09-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06695377 on ClinicalTrials.gov